Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) EBIT (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed EBIT for 9 consecutive years, with $46.1 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 44.62% to $46.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.0 million through Dec 2025, up 41.21% year-over-year, with the annual reading at $51.0 million for FY2025, 41.21% up from the prior year.
  • EBIT hit $46.1 million in Q4 2025 for Inspire Medical Systems, up from $9.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $46.1 million in Q4 2025 to a low of -$19.5 million in Q1 2023.
  • Historically, EBIT has averaged -$2.0 million across 5 years, with a median of -$6.6 million in 2021.
  • Biggest five-year swings in EBIT: soared 2875.22% in 2023 and later crashed 165.03% in 2025.
  • Year by year, EBIT stood at -$1.8 million in 2021, then skyrocketed by 81.6% to -$335000.0 in 2022, then skyrocketed by 2875.22% to $9.3 million in 2023, then surged by 242.95% to $31.9 million in 2024, then skyrocketed by 44.62% to $46.1 million in 2025.
  • Business Quant data shows EBIT for INSP at $46.1 million in Q4 2025, $9.6 million in Q3 2025, and -$3.3 million in Q2 2025.